508 related articles for article (PubMed ID: 30012102)
41. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
42. Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration.
Wisse LEM; Das SR; Davatzikos C; Dickerson BC; Xie SX; Yushkevich PA; Wolk DA;
Neuroimage Clin; 2018; 18():407-412. PubMed ID: 29487798
[TBL] [Abstract][Full Text] [Related]
43. Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
Scott TM; Bhadelia RA; Qiu WQ; Folstein MF; Rosenberg IH
J Alzheimers Dis; 2018; 65(1):293-302. PubMed ID: 30040728
[TBL] [Abstract][Full Text] [Related]
44. Cohort study ON Neuroimaging, Etiology and Cognitive consequences of Transient neurological attacks (CONNECT): study rationale and protocol.
van Rooij FG; Tuladhar AM; Kessels RP; Vermeer SE; Góraj BM; Koudstaal PJ; Norris DG; de Leeuw FE; van Dijk EJ
BMC Neurol; 2015 Mar; 15():36. PubMed ID: 25880287
[TBL] [Abstract][Full Text] [Related]
45. Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy.
Firth NC; Primativo S; Marinescu RV; Shakespeare TJ; Suarez-Gonzalez A; Lehmann M; Carton A; Ocal D; Pavisic I; Paterson RW; Slattery CF; Foulkes AJM; Ridha BH; Gil-Néciga E; Oxtoby NP; Young AL; Modat M; Cardoso MJ; Ourselin S; Ryan NS; Miller BL; Rabinovici GD; Warrington EK; Rossor MN; Fox NC; Warren JD; Alexander DC; Schott JM; Yong KXX; Crutch SJ
Brain; 2019 Jul; 142(7):2082-2095. PubMed ID: 31219516
[TBL] [Abstract][Full Text] [Related]
46. Identifying preclinical vascular dementia in symptomatic small vessel disease using MRI.
Lambert C; Zeestraten E; Williams O; Benjamin P; Lawrence AJ; Morris RG; Mackinnon AD; Barrick TR; Markus HS
Neuroimage Clin; 2018; 19():925-938. PubMed ID: 30003030
[TBL] [Abstract][Full Text] [Related]
47. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
48. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
49. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
50. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
51. Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline.
Ayton S; Fazlollahi A; Bourgeat P; Raniga P; Ng A; Lim YY; Diouf I; Farquharson S; Fripp J; Ames D; Doecke J; Desmond P; Ordidge R; Masters CL; Rowe CC; Maruff P; Villemagne VL; ; Salvado O; Bush AI
Brain; 2017 Aug; 140(8):2112-2119. PubMed ID: 28899019
[TBL] [Abstract][Full Text] [Related]
52. Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer's disease.
Younan D; Petkus AJ; Widaman KF; Wang X; Casanova R; Espeland MA; Gatz M; Henderson VW; Manson JE; Rapp SR; Sachs BC; Serre ML; Gaussoin SA; Barnard R; Saldana S; Vizuete W; Beavers DP; Salinas JA; Chui HC; Resnick SM; Shumaker SA; Chen JC
Brain; 2020 Jan; 143(1):289-302. PubMed ID: 31746986
[TBL] [Abstract][Full Text] [Related]
53. Impaired renal function is associated with brain atrophy and poststroke cognitive decline.
Auriel E; Kliper E; Shenhar-Tsarfaty S; Molad J; Berliner S; Shapira I; Ben-Bashat D; Shopin L; Tene O; Rosenberg GA; Bornstein NM; Ben Assayag E
Neurology; 2016 May; 86(21):1996-2005. PubMed ID: 27164678
[TBL] [Abstract][Full Text] [Related]
54. Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative.
Spencer BE; Jennings RG; Brewer JB;
J Alzheimers Dis; 2019; 68(4):1549-1559. PubMed ID: 30958366
[TBL] [Abstract][Full Text] [Related]
55. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
Bos I; Verhey FR; Ramakers IHGB; Jacobs HIL; Soininen H; Freund-Levi Y; Hampel H; Tsolaki M; Wallin ÅK; van Buchem MA; Oleksik A; Verbeek MM; Olde Rikkert M; van der Flier WM; Scheltens P; Aalten P; Visser PJ; Vos SJB
Alzheimers Res Ther; 2017 Dec; 9(1):101. PubMed ID: 29284531
[TBL] [Abstract][Full Text] [Related]
56. Delayed-onset dementia after stroke or transient ischemic attack.
Mok VCT; Lam BYK; Wang Z; Liu W; Au L; Leung EYL; Chen S; Yang J; Chu WCW; Lau AYL; Chan AYY; Shi L; Fan F; Ma SH; Ip V; Soo YOY; Leung TWH; Kwok TCY; Ho CL; Wong LKS; Wong A
Alzheimers Dement; 2016 Nov; 12(11):1167-1176. PubMed ID: 27327542
[TBL] [Abstract][Full Text] [Related]
57. Methods of a Study to Assess the Contribution of Cerebral Small Vessel Disease and Dementia Risk Alleles to Racial Disparities in Vascular Cognitive Impairment and Dementia.
Sawyer RP; Worrall BB; Howard VJ; Crowe MG; Howard G; Hyacinth HI
J Am Heart Assoc; 2023 Sep; 12(17):e030925. PubMed ID: 37642037
[TBL] [Abstract][Full Text] [Related]
58. Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects.
Araque Caballero MÁ; Klöppel S; Dichgans M; Ewers M;
J Alzheimers Dis; 2017; 55(1):343-358. PubMed ID: 27662291
[TBL] [Abstract][Full Text] [Related]
59. Executive Function Declines in the First 6 Months After a Transient Ischemic Attack or Transient Neurological Attack.
van Rooij FG; Plaizier NO; Vermeer SE; Góraj BM; Koudstaal PJ; Richard E; de Leeuw FE; Kessels RPC; van Dijk EJ
Stroke; 2017 Dec; 48(12):3323-3328. PubMed ID: 29158448
[TBL] [Abstract][Full Text] [Related]
60. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
